RxDoctor Payments Data

Hummira Abawi

Foot & Ankle Surgery · Columbia, MDNPI 1073837217

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $75,000 of the $123,399 with a category attached, or 60.8%. Arthrex accounts for 68.9% of it on its own, with 28 other manufacturers making up the rest. Among foot & ankle surgery clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$123,399in general payments, 2019–2025

Across 291 payments — averaging $424.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$85K
  • Medical Device Business Services, Inc.$22K
  • Supreme Orthopedic Systems, LLC$8K
  • Stryker$3K
  • International Rehabilitative Sciences, Inc$1K
  • Smith+Nephew$1K
  • plus $3K from 23 others

What the payments were for

  • Consulting fees$21,24517%
  • Speaking & faculty fees$75,00061%
  • Travel & lodging$10,4068%
  • Food & beverage$9,3178%
  • Education$6,0275%
  • Other$1,4031%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$123,399 in reported general payments places this provider in the 95th percentile of 182 foot & ankle surgery providers in Maryland.

See all foot & ankle surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$40,795
Medicare patients
94
Services billed
259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole46$497
Ciclopirox11$288

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Columbia

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →